Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Budesonide Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The budesonide market size has shown substantial growth in recent years. This market is set to expand from $10.26 billion in 2025 to $10.88 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.0%. Historically, this expansion has been influenced by factors such as the increasing prevalence of asthma and COPD, the widespread use of corticosteroids, the development of inhalation therapies, a rise in IBD diagnoses, and enhancements in drug delivery technologies.
The budesonide market is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $13.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This projected growth is largely driven by factors such as an aging demographic, the increasing prevalence of chronic inflammatory conditions, a rise in generic drug consumption, the expansion of home-based treatment options, and a growing burden of respiratory illnesses. Key trends expected during this period involve the expanded application of inhaled corticosteroids in chronic respiratory care, greater integration into inflammatory bowel disease treatment, a developing preference for targeted localized steroid therapies, the proliferation of generic budesonide formulations, and wider utilization in long-term maintenance regimens.
Get A Free Sample Report With In-Depth Market Insights:
Budesonide Market Growth Momentum: What Factors Are Shaping Demand?
The rising occurrence of respiratory illnesses is projected to fuel the future growth of the budesonide market. Respiratory diseases are medical conditions affecting the organs and tissues vital for gas exchange in air-breathing animals. This increase in prevalence is attributed to escalating air pollution, particularly exposure to particulate matter and allergens, which significantly impacts the incidence of asthma and chronic obstructive lung disease. Budesonide is utilized in respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) to lessen inflammation, improve airflow, and prevent symptoms like wheezing and shortness of breath. For instance, in August 2025, the Centers for Disease Control and Prevention, a Switzerland-based public health agency, reported that 90% of the nation’s 4.9 trillion dollars in annual health care spending is linked to individuals with chronic and mental health conditions, with more than 84,000 Americans dying each year from heart disease or stroke and the costs associated with cardiovascular diseases projected to reach roughly 2 trillion dollars by 2050. Hence, the increasing prevalence of respiratory diseases is set to drive the expansion of the budesonide market.
Budesonide Market Segmentation And Category Overview
The budesonide market covered in this report is segmented –
1) By Type: Inhalation Powder, Aerosols, Tablets And Capsules
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Respiratory Disease Treatment, Other Applications
Subsegments:
1) By Inhalation Powder: Dry Powder Inhalers (DPI), Soft Mist Inhalers (SMI)
2) By Aerosols: Metered-Dose Inhalers (MDI), Breath-Activated Inhalers
3) By Tablets And Capsules: Oral Tablets, Oral Capsules
Budesonide Market Trends Redefining Industry Growth
Major companies operating in the budesonide market are channeling their focus into advancements in respiratory treatment, such as oral therapy, aiming to elevate patient convenience, foster treatment adherence, and expand the range of therapeutic choices for managing asthma and other respiratory conditions. Oral therapy budesonide represents a budesonide formulation administered by mouth, primarily employed to address inflammatory conditions. For instance, in February 2024, Takeda Pharmaceuticals, a Japan-based pharmaceutical company, announced that EOHILIA, a budesonide oral suspension, had been authorized by the Food and Drug Administration (FDA), a US-based federal agency, marking it as the first and only FDA-approved oral medication for patients aged 11 and above diagnosed with eosinophilic esophagitis (EoE). Additionally, the FDA’s approval of EOHILIA 2 mg twice daily was based on the efficacy and safety data obtained from two multicenter, randomized, double-blind, parallel-group, placebo-controlled 12-week investigations involving individuals aged 11 to 56 who have EoE.
Budesonide Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the budesonide market are AstraZeneca AB, Novartis AG, Takeda Pharmaceuticals Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Lupin Limited, Orion Corporation, Salix Pharmaceuticals Inc., Synmosa Biopharma Corporation, Cosmo Pharmaceuticals N.V., Skyepharma Holdings Inc., Manus Aktteva Biopharma LLP, Cennet Biopharma Private Limited, Santarus Inc., SiNi Pharma Private Limited, Shanghai Sine Promod Pharmaceutical Co. Ltd.
View The Full Budesonide Market Report:
Budesonide Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the budesonide market in 2025. The regions covered in the budesonide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
